Form 4 for ENOV Enovis CORP
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-17 · accession 0000950170-25-023647 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-17 | ENOV | Shirley Brady | Dir | A - Grant | $0.00 | +21.2K | 112.4K | +23% | $0 | |
| 2025-02-19 | 2025-02-17 | ENOV | Shirley Brady | Dir | F - Tax | $43.89 | -9,161 | 103.2K | -8% | -$402.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2025-02-17 | A | A | 21,221 | $0.00 | 112,404 | D | — | — | (F1) Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2022. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2023 Fiscal Year-End" table on page 44 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 5, 2024. |
| 2 | Common | Common stock, par value $0.001 | 2025-02-17 | F | D | 9,161 | $43.89 | 103,243 | D | — | — | (F2) Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of PRSUs and time-based restricted stock units and does not represent a sale by the reporting person. |